European Union - English - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing ltd - imidacloprid, moxidectin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme).the veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (fad). for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis). for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis).the veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (fad).

European Union - English - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing ltd - selamectin - antiparasitic products, insecticides and repellents - cats; dogs - cats and dogs:treatment and prevention of flea infestations caused by ctenocephalides spp. for one month following a single administration. this is as a result of the adulticidal, larvicidal and ovicidal properties of the product. the product is ovicidal for 3 weeks after administration. through a reduction in the flea population, monthly treatment of pregnant and lactating animals will also aid in the prevention of flea infestations in the litter up to seven weeks of age. the product can be used as part of a treatment strategy for flea allergy dermatitis and through its ovicidal and larvicidal action may aid in the control of existing environmental flea infestations in areas to which the animal has access.prevention of heartworm disease caused by dirofilaria immitis with monthly administration.the product may be safely administered to animals infected with adult heartworms, however, it is recommended, in accordance with good veterinary practice, that all animals 6 months of age or more living in countries where a vector exists should be tested for existing adult heartworm infections before beginning medication with the product. it is also recommended that dogs should be tested periodically for adult heartworm infections, as an integral part of a heartworm prevention strategy, even when the product has been administered monthly. this product is not effective against adult d. immitis.treatment of ear mites (otodectes cynotis).cats:treatment of biting lice infestations (felicola subrostratus)treatment of adult roundworms (toxocara cati)treatment of adult intestinal hookworms (ancylostoma tubaeforme)treatment of biting lice infestations (trichodectes canis)treatment of sarcoptic mange (caused by sarcoptes scabiei)

European Union - English - EMA (European Medicines Agency)

chanelle pharmaceuticals manufacturing ltd - meloxicam - anti-inflammatory and anti-rheumatic products, non-steroids - horses; dogs; cats; cattle; pigs - dogs: alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.to reduce post-operative pain and inflammation following orthopaedic and soft tissue surgery.cats: to reduce post-operative pain after ovariohysterectomy and minor soft tissue surgery.alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders in cats.cattle: for use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs.for use in diarrhoea in combination with oral re‑hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.for adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.for the relief of post-operative pain following dehorning in calves.pigs: for use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.for adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.for the relief of post operative pain associated with minor soft tissue such as castration.horses: alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.for the relief of pain associated with equine colic.

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - miconazole nitrate ; prednisolone acetate; polymyxin b sulfate - ear drops, suspension - prednisolone and antiinfectives

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - miconazole nitrate ; prednisolone acetate; polymyxin b sulfate - ear drops, suspension - miconazole, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - pyrantel embonate ; praziquantel - film-coated tablet - 230, 20 mg/tablet - praziquantel, combinations - cats - endoparasiticide

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - enrofloxacin - solution for injection - 50 milligram(s)/millilitre - enrofloxacin - bovine, canine, feline, porcine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - lincomycin hydrochloride; spectinomycin sulfate tetrahydrate - solution for injection - 50, 100 milligram(s)/millilitre - lincomycin, combinations - cats, cattle, dogs, pigs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - praziquantel; pyrantel embonate ; febantel - tablet - 50,50,150 mg/tablet - praziquantel, combinations - dogs - endoparasiticide

Ireland - English - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - praziquantel; pyrantel embonate ; febantel - tablet - 50,50,150 mg/tablet - praziquantel, combinations - dogs - endoparasiticide